|
|
Keynote
Presentations |
 |
Opportunities and Pitfalls of Establishing an R&D Service Organization in India
Antal K. Hajos, Ph.D., Managing Director, ALTANA Pharma Pvt. Ltd. |
|
 |
General Regulatory Considerations for
Contract Manufacturing
Subhash Dhawan, Ph.D., Center for Biologics Evaluation and Research, Food and Drug
Administration |
|
- Protecting Your Intellectual Property: Understanding IP
Barriers and Trends
|
- Strategies for Successful Outsourcing of Chemistry and
Biology
|
- Creating Successful Outsourcing, In-Licensing,
Out-Licensing,
and Risk Sharing Partnerships
|
- Calculating Key Cost
Drivers and Less Obvious Budgetary Pitfalls of Projects
|
- Strategic Planning for Clinical Development Operations in
Asia
|
- Overcoming Challenges in Transferring Technology/Data and
Training Staff
|
|
|
|
|
THREE INTERACTIVE PANELS
 |
Partnership and Outsourcing Deals in India: Successes and Failures |
|
|
|
Planning a Global Strategy around IP Protection |
|
Joseph Cerro, Head Informatics Research, Bayer Pharmaceuticals Corp.
Kamesh Venugopal, President, North America, Torrent Pharma
Fidela Moreno, M.D., Senior Director, Global Development Operations, Asia and Latin
America, Amgen, Inc. |
|
|
Collaborative Research Efforts in India: Opportunities and
Challenges |
|
Patricia Turney, Director, R&D Strategic Operations, Amgen, Inc.
Ramana Sonty, Ph.D., Senior Director, Global Project Management
WorldwideDevelopment, Pfizer Inc.
Dilip Mehta, M.D., Ph.D., former Senior Vice President, US Clinical Research, Pfizer Inc
|
|
Distinguished Presenters
|
Shyam Bishen, Ph.D., MBA, Vice
President, Global Strategy &
Development, Ranbaxy Laboratories
Limited
M. Bhupathy, Ph.D., Director,
Chemical Process R&D,
Amgen, Inc.
George W. Bickerstaff, Managing
Director, CRT Capital Group LLC
and former Chief Financial Officer,
Novartis
Sudhir Borgonha, M.D., Chief Executive Officer, Translational
Medicine India
Subhash Dhawan, Ph.D., Senior Investigator and Chief, Immunopathogenesis Section, Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research,
US Food and Drug Administration
Rakesh Dixit, Ph.D., DABT, Senior
Director of Toxicology, Toxicology
Department, Johnson and Johnson
PRD, L.L.C.
James Freeman, Ph.D., Vice President
Laboratory Sciences, Pfizer Global
R&D
Mak Jawadekar, Ph.D., Director,
WWPM, Pfizer Global R&D
Bryan Kraker, Global Basic and
PreClinical Sourcing,
Merck & Co., Inc.
|
Sundeep Lal, Ph.D., MBA, Senior
Director, External Scientific Affairs,
WW Licensing & External Research,
Merck & Co., Inc.
Sri Mosur, Chief Executive Officer,
Jubilant Biosys
Amit Patel, Vice President,
Corporate Development & Strategic
Planning, Dr. Reddy’s Laboratories,
Inc.
Romi Singh, Ph.D., Director, Global
Strategic Regulatory Development,
Merck & Co., Inc.
Daniel Warner, Strategic External
Resourcing (SER), Novartis
Institutes for BioMedical Research
(NIBR)
Gene Williams, Chief Executive
Officer, Cambridge Healthtech
Associates
|
For more information, please contact:
Micah Lieberman, Conference Director,
Pharmaceutical Strategy Series,
Cambridge Healthtech Institute
Phone: 541-665-1236
Email: mlieberman@pharmaseries.com
For sponsorship &
exhibiting opportunities, please contact:
Laura Ames, Cambridge
Healthtech Institute
Phone: 781-972-5479
Email: lames@healthtech.com
|
